Dr. Hormigo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1695 Eastchester Road and 555 Taxter Rd
Bronx, NY 10461Phone+1 718-405-8404Fax+1 718-405-8433
Summary
- Adilia Hormigo, MD, PhD, is Leader, Neuro-Oncology Program, Co-Leader, Neuro-Oncology Multidisciplinary Disease Team at Montefiore Einstein Cancer Center and Professor, Hematology-Oncology, Neurosurgery, and Microbiology & Immunology at Albert Einstein College of Medicine. Dr. Hormigo’s translational research focuses on new strategies in cancer immunology, including personalized treatment for patients with malignant brain tumors, understanding and overcoming the tumor microenvironment resistance to treatment and defining biomarkers of treatment response. She has been a primary investigator of innovative clinical trials. Her work has been published in numerous peer-reviewed journals.
Education & Training
- New York Presbyterian Hospital (Cornell Campus)Residency, Neurology, 1999 - 2003
- New York UniversityPhD, 1995 - 1999
- Memorial Sloan Kettering Cancer CenterFellowship, Neuro-Oncology, 1992 - 1995
- University of Lisbon Faculty of MedicineClass of 1981
Certifications & Licensure
- NY State Medical License 2002 - 2026
- American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CRI -V Foundation (CLIP) Investigator Cancer Research Institute, 2021
- National Brain Tumor Society, Defeat Brain Tumor National Brain Tumor Society, 2020
- The Memorial Sloan-Kettering Cancer Center Brain Tumor Center Memorial Sloan-Kettering Cancer Center, 2007
- Join now to see all
Clinical Trials
- Safety and Immunogenicity of Personalized Genomic Vaccine and Tumor Treating Fields (TTFields) to Treat Glioblastoma Start of enrollment: 2018 Mar 01
- Avelumab With Laser Interstitial Therapy for Recurrent Glioblastoma Start of enrollment: 2018 Jun 13
- ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the ACTION Study) Start of enrollment: 2023 Jan 23
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Multiparametric Radiogenomic Model to Predict Survival in Patients with Glioblastoma.Keon Mahmoudi, Daniel H Kim, Elham Tavakkol, Shingo Kihira, Adam Bauer
Cancers. 2024-01-30 - 5 citationsUsing EGFR amplification to stratify recurrent glioblastoma treated with immune checkpoint inhibitors.Joshua S Friedman, Tomi Jun, Omid Rashidipour, Kuan-Lin Huang, Ethan Ellis
Cancer Immunology, Immunotherapy. 2023-06-01 - 7 citationsMulti-Parametric Radiomic Model to Predict 1p/19q Co-Deletion in Patients with IDH-1 Mutant Glioma: Added Value to the T2-FLAIR Mismatch Sign.Shingo Kihira, Ahrya Derakhshani, Michael Leung, Keon Mahmoudi, Adam Bauer
Cancers. 2023-02-07
Journal Articles
- A Phase I Trial of VEGF-A Inhibition Combined with PD-L1 Blockade for Recurrent GlioblastomaDaniel Chiu1 , Jingjing Qi 2 , Tin Htwe Thin3 , Monica Garcia-Barros 3 , Brian Lee 2 , Mary Hahn1 , John Mandeli4 , Puneet Belani 5 , Kambiz Nael 6 , Omid Rashidipour ..., Cancer Resarch Communications, 1/25/2023
Press Mentions
- Personalised Cancer Vaccines Are Finally Beating Hard to Treat TumoursJune 22nd, 2022
- New Investigational Helmet Device Shrinks GlioblastomaJuly 30th, 2021
Professional Memberships
- Member
- American Neurological AssociationFellow
- Society for Neuro-OncologyMember
- American Society for Clinical OncologyMember
- American Association for Cancer ResearchMember
- The Society for the Immunotherapy of CancerMember
Other Languages
- Portuguese, Spanish, French
External Links
- Albert Einstein College of Medicinehttps://www.einsteinmed.edu/faculty/17230/adilia-hormigo/
- Montefiore EinsteinCancer Centerhttps://cancer.montefioreeinstein.org/doctors/profiles/1427029461/adilia-hormigo
- Montefiorehttps://www.montefiore.org/doctors/profiles/1427029461/adilia-hormigo
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: